Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 306

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus

Herrmann, Howard C., Mehran, Roxana, Blackman, Daniel J., Bailey, Stephen, Möllmann, Helge, Abdel-Wahab, Mohamed, Ben Ali, Walid, Mahoney, Paul D., Ruge, Hendrik, Wood, David A., Bleiziffer, Sabine, Ramlawi, Basel, Gada, Hemal, Petronio, Anna Sonia, Resor, Charles D., Merhi, William, Garcia del Blanco, Bruno, Attizzani, Guilherme F., Batchelor, Wayne B., Gillam, Linda D., Guerrero, Mayra, Rogers, Toby, Rovin, Joshua D., Szerlip, Molly, Whisenant, Brian, Deeb, G. Michael, Grubb, Kendra J., Padang, Ratnasari, Fan, Myra T., Althouse, Andrew D., Tchétché, Didier·2024·New England Journal of Medicine

Abstract

Background Patients with severe aortic stenosis and a small aortic annulus are at risk for impaired valvular hemodynamic performance and associated adverse cardiovascular clinical outcomes after transcatheter aortic-valve replacement (TAVR). Methods We randomly assigned patients with symptomatic severe aortic stenosis and an aortic-valve annulus area of 430 mm 2 or less in a 1:1 ratio to undergo TAVR with either a self-expanding supraannular valve or a balloon-expandable valve. The coprimary end points, each assessed through 12 months, were a composite of death, disabling stroke, or rehospitalization for heart failure (tested for noninferiority) and a composite end point measuring bioprosthetic-valve dysfunction (tested for superiority). Results A total of 716 patients were treated at 83 sites in 13 countries (mean age, 80 years; 87% women; mean Society of Thoracic Surgeons Predicted Risk of Mortality, 3.3%). The Kaplan–Meier estimate of the percentage of patients who died, had a disabling stroke, or were rehospitalized for heart failure through 12 months was 9.4% with the self-expanding valve and 10.6% with the balloon-expandable valve (difference, −1.2 percentage points; 90% confidence interval [CI], −4.9 to 2.5; P<0.001 for noninferiority). The Kaplan–Meier estimate of the percentage of patients with bioprosthetic-valve dysfunction through 12 months was 9.4% with the self-expanding valve and 41.6% with the balloon-expandable valve (difference, −32.2 percentage points; 95% CI, −38.7 to −25.6; P<0.001 for superiority). The aortic-valve mean gradient at 12 months was 7.7 mm Hg with the self-expanding valve and 15.7 mm Hg with the balloon-expandable valve, and the corresponding values for additional secondary end points through 12 months were as follows: mean effective orifice area, 1.99 cm 2 and 1.50 cm 2 ; percentage of patients with hemodynamic structural valve dysfunction, 3.5% and 32.8%; and percentage of women with bioprosthetic-valve dysfunction, 10.2% and 43.3% (all P<0.001). Moderate or severe prosthesis–patient mismatch at 30 days was found in 11.2% of the patients in the self-expanding valve group and 35.3% of those in the balloon-expandable valve group (P<0.001). Major safety end points appeared to be similar in the two groups. Conclusions Among patients with severe aortic stenosis and a small aortic annulus who underwent TAVR, a self-expanding supraannular valve was noninferior to a balloon-expandable valve with respect to clinical outcomes and was superior with respect to bioprosthetic-valve dysfunction through 12 months. (Funded by Medtronic; SMART ClinicalTrials.gov number, NCT04722250 .)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2312573

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 306

Metadata

Authors
Herrmann, H. C., Mehran, R., Blackman, D. J., Bailey, S., Möllmann, H., Abdel-Wahab, M., Ben Ali, W., Mahoney, P. D., Ruge, H., Wood, D. A., Bleiziffer, S., Ramlawi, B., Gada, H., Petronio, A. S., Resor, C. D., Merhi, W., Garcia del Blanco, B., Attizzani, G. F., Batchelor, W. B., Gillam, L. D., Guerrero, M., Rogers, T., Rovin, J. D., Szerlip, M., Whisenant, B., Deeb, G. M., Grubb, K. J., Padang, R., Fan, M. T., Althouse, A. D., & Tchétché, D.
Venue
New England Journal of Medicine
Published
2024-06-06
Volume
390
Issue
21
Pages
1959-1971
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4394062014
Cited by
306
References
36
FWCI
82.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus. https://app.cochat.ai/papers/10.1056/nejmoa2312573
The paper
Herrmann, H. C., Mehran, R., Blackman, D. J., Bailey, S., Möllmann, H., Abdel-Wahab, M., Ben Ali, W., Mahoney, P. D., Ruge, H., Wood, D. A., Bleiziffer, S., Ramlawi, B., Gada, H., Petronio, A. S., Resor, C. D., Merhi, W., Garcia del Blanco, B., Attizzani, G. F., Batchelor, W. B., . . . Tchétché, D. (2024). Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2312573

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.